JACC Asia - Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4): A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

Commentary by Dr Jian-Jun Li

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.